BRKR Bruker Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: BRKR

Price (delayed)

$69.33

Market cap

$10.51B

P/E Ratio

67.31

Dividend/share

$0.16

EPS

$1.03

Enterprise value

$10.72B

Sector: Healthcare
Industry: Medical Devices
Website: https://www.bruker.com/

Highlights

BRKR's equity is up by 6% YoY
BRKR's price to earnings (P/E) is 75% higher than its 5-year quarterly average of 38.4 and 67% higher than its last 4 quarters average of 40.3
The net income has declined by 20% year-on-year

Key stats

What are the main financial stats of BRKR
Market
Shares outstanding
151.57M
Market cap
$10.51B
Enterprise value
$10.72B
Valuations
Price to earnings (P/E)
67.31
Price to book (P/B)
11.04
Price to sales (P/S)
5.35
EV/EBIT
48.23
EV/EBITDA
35.42
EV/Sales
5.39
Earnings
Revenue
$1.99B
EBIT
$222.2M
EBITDA
$302.6M
Free cash flow
$235.2M
Per share
EPS
$1.03
Free cash flow per share
$1.53
Book value per share
$6.28
Revenue per share
$12.96
TBVPS
$16.29
Balance sheet
Total assets
$3.05B
Total liabilities
$2.07B
Debt
$891.5M
Equity
$961.2M
Working capital
$1.13B
Liquidity
Debt to equity
0.93
Current ratio
2.43
Quick ratio
1.35
Net debt/EBITDA
0.69
Margins
EBITDA margin
15.2%
Gross margin
47.3%
Net margin
7.9%
Operating margin
12.5%
Efficiency
Return on assets
5.3%
Return on equity
16.9%
Return on invested capital
11.7%
Return on capital employed
9.8%
Return on sales
11.2%
Dividend
Dividend yield
0.23%
DPS
$0.16
Payout ratio
15.5%

BRKR stock price

How has the Bruker stock price performed over time
Intraday
1.66%
1 week
1.18%
1 month
2.96%
1 year
74.24%
YTD
28.08%
QTD
7.86%

Financial performance

How have Bruker's revenue and profit performed over time
Revenue
$1.99B
Gross profit
$939.8M
Operating income
$248.3M
Net income
$157.8M
Gross margin
47.3%
Net margin
7.9%
The net income has declined by 20% year-on-year
BRKR's operating income is down by 17% year-on-year
Bruker's net margin has decreased by 17% YoY
BRKR's operating margin is down by 14% YoY and by 3.1% QoQ

Growth

What is Bruker's growth rate over time

Valuation

What is Bruker stock price valuation
P/E
67.31
P/B
11.04
P/S
5.35
EV/EBIT
48.23
EV/EBITDA
35.42
EV/Sales
5.39
BRKR's price to earnings (P/E) is 75% higher than its 5-year quarterly average of 38.4 and 67% higher than its last 4 quarters average of 40.3
BRKR's EPS is down by 19% year-on-year
The stock's price to book (P/B) is 67% more than its 5-year quarterly average of 6.6 and 58% more than its last 4 quarters average of 7.0
BRKR's equity is up by 6% YoY
The stock's price to sales (P/S) is 84% more than its 5-year quarterly average of 2.9 and 62% more than its last 4 quarters average of 3.3
Bruker's revenue has decreased by 4.1% YoY

Efficiency

How efficient is Bruker business performance
Bruker's return on invested capital has decreased by 40% YoY and by 6% QoQ
BRKR's return on assets is down by 35% year-on-year and by 3.6% since the previous quarter
Bruker's return on equity has decreased by 25% YoY
BRKR's return on sales is down by 17% year-on-year and by 4.3% since the previous quarter

Dividends

What is BRKR's dividend history
DPS
$0.16
Dividend yield
0.23%
Payout ratio
15.5%
Recent dividends

Financial health

How did Bruker financials performed over time
BRKR's total assets is 47% greater than its total liabilities
The quick ratio has decreased by 17% YoY and by 2.9% from the previous quarter
BRKR's current ratio is down by 13% year-on-year and by 9% since the previous quarter
Bruker's debt is 7% less than its equity
BRKR's equity is up by 6% YoY
Bruker's debt has increased by 3.6% YoY and by 2.2% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.